Name | Description | Funding Type | Funded Company | Funding Round Amount (USD) | Investment | Funding Round Date | ||
---|---|---|---|---|---|---|---|---|
InMed Pharmaceuticals raised a Initial public offering (IPO) for 6,000,000 USD in November, 2022. | 6,000,000 | November 2022 | ||||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 12,000,000 USD in June, 2021. | 12,000,000 | June 2021 | ||||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 5,000,000 USD in June, 2022. | 5,000,000 | June 2022 | ||||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 11,344,500 USD in June, 2018. | 11,344,500 | Funding Round Investor | June 2018 | |||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 7,108,000 USD in January, 2018. | 7,108,000 | January 2018 | ||||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 6,000,000 USD in September, 2022. | 6,000,000 | September 2022 | ||||||
InMed Pharmaceuticals raised a Initial public offering (IPO) for 8,000,000 USD in November, 2020. | 8,000,000 | November 2020 |